Current Pharmaceutical Design
Title:Editorial(Current and Future Options for Lipid-lowering Therapy Beyond Statins)
Volume: 19 Issue: 17
Author(s): Ioanna Gouni-Berthold
Affiliation:
Export Options
About this article
Cite this article as:
Gouni-Berthold Ioanna, Editorial(Current and Future Options for Lipid-lowering Therapy Beyond Statins), Current Pharmaceutical Design 2013; 19 (17) . https://dx.doi.org/10.2174/1381612811319170015
DOI https://dx.doi.org/10.2174/1381612811319170015 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diabetes-Induced Alterations in Renal Medullary Microcirculation and Metabolism
Current Diabetes Reviews 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents
Letters in Drug Design & Discovery Effect of a Physical Activity Program on Serum Biochemical Parameters among the Elderly Women
Reviews on Recent Clinical Trials The Follow-Up of Dietary Treatment of Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Why Does Obesity Increase the Risk for Cardiovascular Disease?
Current Pharmaceutical Design Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease: Does the Actual Knowledge Justify a Clinical Approach?
Current Vascular Pharmacology Clopidogrel in Secondary Ischemic Stroke Prevention
Recent Patents on Cardiovascular Drug Discovery Low-Molecular-Weight-Heparins: A Review of Literature
Vascular Disease Prevention (Discontinued) Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders
Current Medicinal Chemistry Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention
Current Pharmaceutical Design The Involvement of PPARs in the Causes, Consequences and Mechanisms for Correction of Cardiac Lipotoxicity and Oxidative Stress
Current Molecular Pharmacology Rationale for Development of New Oral Anticoagulants
Cardiovascular & Hematological Disorders-Drug Targets Compared Chemical Activity and Effects on Cell Viability of Various Antioxidant Compounds
Current Analytical Chemistry Patenting Human Genes and Stem Cells
Recent Patents on DNA & Gene Sequences Liver Transporters in Hepatic Drug Disposition: An Update
Current Drug Metabolism The Renin-Angiotensin System: New Insight into Old Therapies
Current Medicinal Chemistry Risk Factors for Development of Heart Failure
Current Cardiology Reviews Modulators of Networks: Molecular Targets of Arterial Calcification Identified in Man and Mice
Current Pharmaceutical Design Role of Heme Oxygenase-1 in Vascular Disease
Current Pharmaceutical Design Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Current Cardiology Reviews